Table 5.

Univariate and multivariate analysis in relation to RFS among 84 ERα (+) and node (−) breast cancer patient samples from public data sets.

GENES	UNIVARIATE			MULTIVARIATE
	HAZARD RATIO	95% CI	P-VALUE	HAZARD RATIO	95% CI	P-VALUE	LIKELIHOOD RATIO
GATA3	0.451	0.06059 to 3.606	0.4656	N/A
NTN4	0.2637	0.02665 to 1.949	0.1769	N/A
SLC7A8	0	0.007922 to 0.5021	0.009	NS
MLPH	N/A	N/A	0.172	N/A
ENPP1	0.2637	0.02665 to 1.949	0.1769	N/A
LAMB2	0	0.01232 to 0.7328	0.0239	NS
PLAT	4.5	0.7140 to 78.62	0.0931	N/A

Note: Significant P-values are in italics.

Abbreviations: NS, non-significant; N/A, not available; CI, confidence interval; RFS, relapse-free survival; ER, estrogen receptor.